Pharma

Changes in pharma CFOs roles: Ernst & Young survey
Changes in pharma CFOs roles: Ernst & Young survey

A latest Ernst & Young survey of Chief financial officers (CFOs) in the Indian pharmaceutical sector underscores important changes in the role of the CFO and the finance function in driving the success of pharmaceutical companies. Respondents of the India CFO survey envisaged a change in their responsibilities, with an increased focus on serving as business partners and managing growth.

ALERT project looks to ICT for drug safety
ALERT project looks to ICT for drug safety

A new EU-funded information and communication technology (ICT) project is tackling issues of safety in newly developed drugs. Over the next three and a half years, the ALERT (‘Early detection of adverse drug events by integrative mining of clinical records and biomedical knowledge’) project partners will work on an innovative computer system for a better and faster detection of adverse drug reactions (ADRs).

Wockhardt hiving off R&D business
Wockhardt hiving off R&D business

Drug maker Wockhardt has announced it will spin off its R&D business and list the new company on stock exchange on January 1, 2009. The company thus has followed similar moves by other pharma companies, who have hived off their research and development units.

Blogs new window to the world for Pharma industry
Blogs new window to the world for Pharma industry

Pharma blogs are playing an important role in shaping the future of the pharmaceutical industry in India. Many Indian online financial portal and investment firms as well as research organisations have provided a blogging platform for the pharma industry to keep itself updated with the development in the pharma world through open and uncensored discussion.

whatsapp--v1